Artificial Intelligence for Highly Myopic Cataract
Recruiting
Observational Study
Cataract
High Myopia
Myopia
Automatic Judgement
Risk Reduction
Diagnoses Disease
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Sex
- Any
- Study type
- Observational
- Participants needed
- 500,000 (estimated)
- Sponsor
- Shanghai High Myopia Study Group · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This study aims to establish a multi-center artificial intelligence model for the accurate calculation of intraocular lens and its clinical application in highly myopic cataract, so as to improve the accuracy of the prediction of postoperative diopter in highly myopic cataract patients.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
Axial length ≥ 26 mm and patients with high myopia complicated by cataracts who visit our hospital.
Preoperative anterior segment photography and cataract severity assessment, along with fundus OCT examination, have been performed.
If surgical treatment is conducted, the posto…